Q: Jeffrey Mandel (a director on Covalon's Board) sent one of his periodic e-mails directly to COV investors. Today's message included a PDF attachment of a 25pp research document COV apparently commissioned from Zacks Small Cap Research in Chicago. Unsurprisingly, the analysis is glowing, which stated, in part, "We forecast Covalon to generate revenue and EPS of C$53.4M and C$0.13 in 2019 and C$64.5M and C$0.30 in 2020. We value Covalon using a combination of P/S and P/E methodologies. Based on analyst's revenue and EPS estimates of publicly traded companies in focused on wound care and medical supplies, infection control and vascular products, we calculate fair value of Covalon at ~C$11.2/share, or US$8.50 based on current exchange rates."
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: what is the connection between these 2 companies?
thanks.
thanks.
Q: Hi Team,
Could you tell us the story behind today's 10% jump please.
Thanks!
Could you tell us the story behind today's 10% jump please.
Thanks!
Q: FSZ has taken quite a beating today. Any idea what's causing it? Time to buy more?
Q: SYZ has been moving slowly downward the past while. Anything to be concerned with? I realize it's a low volume trader and more volatile. What will it take to kick start the stock?
Q: Is ENGH value buy at this price? Thanks for your help.
Q: I'm thinking of investing in this company. Considering the slow down in the economy, consumer high debt in Canada and possible upcoming recession, I think this is one of the few consumer discretionary companies that might not be too affected. Your thoughts on this company, please.
Many thanks for your great service!
Jen
Many thanks for your great service!
Jen
Q: In reference to your answer to Roy on March 29. While I appreciate your answer to the question asked, it leaves me as an existing stockholder wondering if you are implying a sell recommendation above $15.00
Hope you understand my thought on this.
Thanks
John
Hope you understand my thought on this.
Thanks
John
Q: Put in an order to SIS this am. It ran away from me. Based on valuation what would you consider a fair bid for this stock?
Q: Which companies are KXS' key competitors and what competitive advantages might KXS or its competitors have over each other?
Q: $17.28p/p, now 3.5% position. Positive market response to Q results even though missed estimated eps. Is it time for me to add? Thanks for u usual great services & views
Q: Morning guys:
I owned this in the past. Would this be a good entry point now for a long term hold.
Thx
Mark
I owned this in the past. Would this be a good entry point now for a long term hold.
Thx
Mark
Q: HI how money is this company putting into upgrades of their property's... they seem to be putting a lot of money into building out, and machines etc. from what I have seen. Their customer base are baby Boomers, which is not a grow group.
Q: Can you summarize what if anything we should take away from TSGI's guidance yesterday? It seems like it was designed to encourage the market but didn't quite have the desired effect. Was there anything new there and if so did it validate the decision a lot of us have made to hold?
-
Stars Group Inc. (The) (TSGI $37.49)
-
TFI International Inc. (TFII $133.86)
-
Premium Brands Holdings Corporation (PBH $95.72)
Q: Right now all of my stocks are up expect for three which I am down significantly in: TFII. TSGI, PBH. I am thinking of taking my losses on these three. I realize that not all stocks in a portfolio will be up at the same time, but the market has been on fire lately with even boring stocks soaring, which makes me concerned that these stocks are down for a reason and will fall even more if we have a recession. What are your thoughts?
Q: Please comment on results and going forward.EPS missed estimates again Thanks for u usual great services & views
Q: I have 2% position of SYZ in my portfolio and with this stock failed to gain any traction, and also dropping almost daily (I'm down 10% so far overall), would it be advisable to just sell it for a small loss and move on? Your recommendation is much appreciated.
-
CCL Industries Inc. Unlimited Class B Non-Voting Shares (CCL.B $83.91)
-
Richards Packaging Income Fund (RPI.UN $33.05)
Q: I have a question about Richard's Packaging Income Fund ; I am looking to put new money in either CCL or RPI. 5-year time horizon. Is there a preference?
Q: As a follow up to my earlier question about GSY. I see their Free Cash Flows are highly variable over the past few years and were negative (-228 million) in 2018. With negative cash flows, how do they cover their dividend, and what is they payout ratio?
C.
C.
Q: Hi,
With the takeover of GS, I'm looking for a new name in the world of Canadian Finance. I can't find a company that pays the great divy (with special) that GS did, so I'm looking for some growth. With the recent pullback of GSY, would you support moving my cash into GSY as a within-sector replacement?
When did GSY last raise their divvy and did they give a reason why?
Cam
With the takeover of GS, I'm looking for a new name in the world of Canadian Finance. I can't find a company that pays the great divy (with special) that GS did, so I'm looking for some growth. With the recent pullback of GSY, would you support moving my cash into GSY as a within-sector replacement?
When did GSY last raise their divvy and did they give a reason why?
Cam